Guest Commentary: Evaluating Pete Hegseth's 'High-T' Department of War

Clinical hypogonadism is a medical condition defined by abnormally low testosterone production and observable physical symptoms. A veteran reviews his annual health assessment on a clinic computer screen. A single blood test flags his hormone levels as mathematically low. He now faces a difficult decision between standard medical protocols and a new interpretation of military readiness.

Defense Secretary Pete Hegseth recently announced a shift toward routine testosterone screening in military health assessments. The reported policy would provide annual testosterone screening for service members aged 30 and older. Younger personnel would be allowed to opt in voluntarily. Hegseth has presented testosterone maintenance as relevant to military readiness and lethality, and the initiative was publicly announced under the label of the "High-T Department of War."

The Standard-Examiner guest commentary was written by Robert A. Rees and Clifton Jolley and argues that the policy reflects an exaggerated or theatrical version of military machismo. The authors warn that confusing physical optimization with true combat effectiveness creates significant health risks. Critics are concerned that broad screening could produce overdiagnosis and unnecessary therapy. This approach runs counter to how modern endocrinology handles testosterone and hormones in clinical settings.

Why Hormone Systems Require Careful Evaluation

Testosterone does not operate like a simple fuel gauge that only needs refilling. It is a dynamic system that responds constantly to environment, stress, and physical exertion. The cited medical coverage emphasizes that testosterone levels vary significantly throughout the day. Because of this natural fluctuation, medical professionals agree that diagnosis should not rest on a single measurement.

A low testosterone result is not automatically equivalent to testosterone deficiency. Symptoms commonly associated with low testosterone include fatigue, low mood, reduced strength, and changes in sexual function. However, these signs often overlap with sleep problems, daily stress, medications, and chronic illness. Treating a laboratory value without addressing lifestyle factors often leads to poor long-term outcomes.

Active duty personnel routinely experience severe physical stress and interrupted sleep cycles. These environmental factors naturally suppress hormone production without indicating a permanent medical failure. A population-level screening program could misidentify temporary stress responses as chronic medical conditions. The available sources do not provide evidence that annual testing of personnel over 30 improves readiness, retention, deployment performance, or mortality.

The commentary and cited medical reporting identify fertility, hormonal, cardiovascular, and testicular effects as potential concerns. These complications require serious clinical counseling before any treatment begins. A readiness-oriented culture could encourage treatment for performance reasons rather than confirmed deficiency. Unnecessary hormone therapy carries lasting consequences like infertility and testicular shrinkage.

How Cardiovascular Risks Complicate Treatment

The intersection of hormone therapy and heart health remains a critical subject in preventative medicine. Health reporting on the 2023 TRAVERSE study says testosterone replacement did not increase overall major cardiovascular-event risk in the studied men with hypogonadism. This finding provides some reassurance for patients treating a confirmed medical condition. However, this study involved men with medically diagnosed hypogonadism under strict treatment conditions.

The TRAVERSE study findings should not be generalized automatically to healthy service members. The results also do not apply to unstudied doses or people without confirmed medical deficiency. Medically supervised replacement is fundamentally different from unsupervised aesthetic enhancement. Medical guidelines firmly distinguish between treating a disease and attempting physiological optimization.

The available coverage also reports that testosterone or anabolic-hormone use may be associated with cardiovascular complications. These complications include heart attack, stroke, arrhythmia, and thrombosis. These risks are particularly concerning when hormones are used for aesthetic or performance purposes. Any medical intervention that alters natural body chemistry requires strict oversight and clear informed consent.

How To Identify Normal Hormonal Function

Establishing a baseline for normal hormonal health requires adherence to strict clinical protocols. FDA labeling limits testosterone products to men with hypogonadism. This is a specific medical condition involving abnormally low testosterone that disrupts normal bodily function. The medical criticism reported in the coverage is that universal or age-based screening may identify low laboratory values without establishing clinically meaningful testosterone deficiency.

The available reporting says physicians generally discuss testosterone therapy with men who have symptoms consistent with low testosterone and documented low hormone levels on two separate blood tests. The timing of these diagnostic tests is critical for accuracy. Testosterone varies during the day, making test timing incredibly important. The available medical coverage says morning testing is preferred and that a low result is commonly repeated.

Reporting characterized the initiative as running counter to prevailing clinical practice. Modern medicine considers treatment when a patient has compatible symptoms and repeatedly documented low levels. Treatment is not recommended solely because of age or a single screening result. Normal health requires looking at the entire patient rather than a single numerical metric.

A diagnosis requires looking past the laboratory sheet to observe the patient's daily life. Proper diagnosis requires ruling out other potential causes for fatigue and reduced strength. Poor nutrition, chronic pain, and previous injuries can all mimic the physical symptoms of hormone deficiency. Medical professionals must evaluate these overlapping factors before prescribing a lifelong pharmaceutical regimen.

Why Policy Details Matter For Service Members

The public evidence base for this new military screening policy remains incomplete. The available sources do not establish the exact definition of low testosterone. It is also unclear whether testing will measure total testosterone, free testosterone, or both. These missing details complicate the relationship between medical practice and military health policy.

The guest commentary says the Pentagon has not yet detailed how the screening standards would apply to female service members. Women naturally have substantially lower testosterone levels than men. Using standard male ranges to assess female readiness lacks a clear medical foundation. The guest authors noted that several senators have asked for clarification about the policy's application to women.

Military personnel should seek clarification about whether participation is truly voluntary. The public sources do not yet answer how results affect medical records or readiness determinations. It remains unknown what appeal or second-opinion procedures exist for abnormal results. Until formal guidance is published, service members should treat claims that testosterone replacement will improve combat lethality as policy assertions rather than established outcomes.

A screening program could identify service members with genuine hypogonadism who might benefit from treatment. However, the current lack of transparency creates confusion for active duty personnel. Service members concerned about fertility should raise that issue before treatment because the commentary identifies infertility and hormonal disruption among potential consequences. The long-term impact on a military career remains entirely undefined by the available reporting.

Why You Must Consult A Physician First

The health information provided by BattleVet is purely for educational purposes and does not replace professional medical judgment. Service members and veterans must consult a qualified physician or a VA provider before starting any medical treatment. You should never self-diagnose a hormone condition based on internet research or a single routine blood test. Always discuss your physical symptoms and evaluate all treatment alternatives with a licensed medical professional.

How To Navigate Hormone Screening Today

Many former service members seek ways to maintain their physical capabilities as they age. This desire for continued strength is understandable, but it should not override sound medical science. Veterans considering TRT through civilian or VA care should request an individualized evaluation rather than pursuing treatment solely because of age, gym performance goals, or a single laboratory value. Proper medical care prioritizes long-term health over short-term physiological enhancement.

Before starting testosterone replacement, patients should ask what symptoms and laboratory findings support the diagnosis. You must also ask whether testing was repeated, what alternatives were evaluated, and what follow-up monitoring is required. Evaluating your sleep, stress and resilience is a necessary step before accepting pharmaceutical intervention.

Key takeaway: Never accept a testosterone deficiency diagnosis based on a single screening test without demanding a second morning blood draw and a comprehensive clinical evaluation.

Sources

1. Guest opinion: Pete Hegseth's High-T Department of War
2. Defense Department reports more than 750 troops wounded, including 580 army soldiers